Showing 1 - 6 of 6
Stepping up HIV fight
Oped, Editorial, Published on 30/06/2025
» The recent news of Gilead Sciences' groundbreaking new HIV preventative drug, Lenacapavir, offers a beacon of hope in the fight against HIV. With a remarkable 96% efficacy in reducing HIV infection and the convenience of only two injections per year, Lenacapavir holds the potential to be a true game-changer in the global effort to halt the transmission of HIV.
Too soon to be endemic?
Oped, Editorial, Published on 28/04/2022
» The Prayut Chan-o-cha government must pay heed to recommendations by some medical experts that it should not rush to declare Covid-19 as an endemic disease given that the situation has not significantly improved.
Act now on favipiravir
Oped, Editorial, Published on 04/08/2021
» Access to medicine can make a life-and-death difference amid the Covid-19 emergency. The government cannot afford to fail in the crucial mission of securing enough of the antiviral medication favipiravir to cover the rapid increase of patients.
Expats fear jabs are not for them
Oped, Editorial, Published on 09/05/2021
» As Covid cases and the death toll in Thailand steeply climbs, Dr Opas Kankawinpong, head of the Disease Control Department, on Thursday came out to pacify fears of the foreign community in Thailand -- at last.
Time for drug policy rethink
News, Editorial, Published on 17/01/2021
» The deaths of nine people last week from the overdose of a deadly "new" drug -- a combination of heroin, ketamine, methamphetamine and sleep medication -- is a shock.
Stop Aids tests in workplace
Oped, Editorial, Published on 03/12/2020
» Thailand has joined global campaigners in marking World Aids Day this week with encouraging news: new cases are on a steady decline.